Skip to content

Ganglion Resection Effectiveness Trial

GangLion Resection Effectiveness Trial (GangLion): a Multicentre, Randomized, Superiority Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07162415
Acronym
GangLion
Enrollment
220
Registered
2025-09-09
Start date
2026-01-13
Completion date
2035-12-01
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Connective Tissue Disease, Ganglion, Ganglion Cyst, Mucinoses, Wrist Ganglion

Keywords

ganglion, wrist

Brief summary

The goal of this clinical trial is to learn if surgery helps with wrist ganglions in adults. The main question it aims to answer is: * Does surgery result in better patient-reported outcomes and satisfaction over a 6-months follow-up period? Researchers will compare surgery to conservative treatment (self-administered exercises and use of the hand as tolerated) to see if surgery provides superior outcomes. Participants will: * Be randomly assigned to receive either surgery or conservative treatment * Complete questionnaires about wrist pain, function, quality of life, satisfaction, and recovery at 3, 6, and 12 months

Detailed description

Wrist ganglions are the most common soft tissue tumors of the hand and also the most frequently excised hand lesions. Despite their high prevalence, the best treatment remains uncertain, as earlier studies have provided conflicting evidence and randomized controlled data are scarce. This study is a multicenter, randomized, controlled, superiority trial comparing surgical excision with conservative care in adults with a painful wrist ganglion. The trial is conducted in Finland and Singapore, with participants randomized in equal groups. Follow-up continues for 12 months, with primary evaluation at 6 months. The study protocol has been reviewed and approved by the regional ethics committee. Written informed consent will be obtained from all participants prior to enrollment. Results will be published in peer-reviewed journals and presented at scientific meetings to inform clinical decision-making for patients with wrist ganglions.

Interventions

PROCEDUREOpen resection

A transverse or longitudinal incision is done depending on surgeon's preference. The ganglion and its pedicle are traced up to its origin. The pedicle is resected tangentially, usually, from the SL ligament for dorsal ganglions and depending on the site for volar ganglion. Wrist capsule is not closed.

Portals are selected by surgeon's preference. The pedicle of the ganglion is located and resected with a shaver. It is not necessary to remove all the ganglion walls. The portal incisions do not need to be sutured.

OTHERConservative treatment

Participant will be informed about the natural course of wrist ganglions. The conservative treatment may include needle aspiration of the ganglion, but it is not performed routinely. Participants are informed that wrist loading in extension may exacerbate the pain, and that the pain is not a sign of further injury to wrist joint. They can avoid heavy use it if they have too much pain, but they are advised to use hand as tolerated. Participants may use NSAIDs and acetaminophen for pain management as needed; however, the protocol does not specify a required course or dosage. A simple self-implemented exercise therapy instructions are given to every participant.

Sponsors

Tampere University Hospital
Lead SponsorOTHER
Tampere University
CollaboratorOTHER
Hospital Nova of Central Finland
CollaboratorUNKNOWN
National University Hospital, Singapore
CollaboratorOTHER
Helsinki University Central Hospital
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Due to the nature of the interventions and inability to blind the participants with placebo surgery (as the visible mass would reveal the allocation after surgery), blinding is not possible. Since the outcomes are participant reported, we will not attempt to blind the investigator or other personnel.

Intervention model description

The trial design is multicentre, randomized, parallel group (1:1) controlled, superiority trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* wrist pain located in the ganglion area * diagnosis of ganglion of the wrist, based on clinical examination or imaging findings * age over 18 years * ability to fill out the Finnish or English version of the questionnaires

Exclusion criteria

* pregnant or breast feeding * other known wrist pathology that likely explains the pain * previous surgical treatments of the wrist * wrist ganglion presumed to be related to a work injury

Design outcomes

Primary

MeasureTime frameDescription
Patient-Rated Wrist/Hand Evaluation (PRWHE) pain score6 months follow-upsThe PRWHE is a 15-item questionnaire that is designed to measure wrist pain and disability in activities of daily living. Symptoms are described as average over the past week. The PRWHE consists of two subscales: pain and function. The PRWHE pain includes five items with combined score from 0 (no pain) to 50 (worst ever).

Secondary

MeasureTime frameDescription
PRWHE pain score3 and 12 months follow-upsThe PRWHE is a 15-item questionnaire that is designed to measure wrist pain and disability in activities of daily living. Symptoms are described as average over the past week. The PRWHE consists of two subscales: pain and function. The PRWHE pain includes five items with combined score from 0 (no pain) to 50 (worst ever).
PRWHE function score3, 6, and 12 months follow-upsThe PRWHE is a 15-item questionnaire that is designed to measure wrist pain and disability in activities of daily living. Symptoms are described as average over the past week. The PRWHE consists of two subscales: pain and function. Score of the PRWHE function ranges from 0 (no difficulty) to 50 (unable to do).
PRWHE total score3, 6, and 12 months follow-upsThe PRWHE is a 15-item questionnaire that is designed to measure wrist pain and disability in activities of daily living. Symptoms are described as average over the past week. The PRWHE consists of two subscales: pain and function. The PRWHE total ranges from 0 (best) to 100 (worst).
Global improvement3, 6, and 12 months follow-upsSelf-reported global improvement will be gathered as 7-step Likert scale as a response to question: "Compared with the beginning of the study, my wrist feels much worse - somewhat worse - little worse - no change - little better - somewhat better - much better."
Patient Accepted Symptom State (PASS)3, 6, and 12 months follow-upsPASS will be assessed using the question: "Considering the current symptoms and function of your wrist, are you satisfied with the outcome?" Participants will respond with either 'yes' or 'no'.
Health-related quality of life3, 6, and 12 months follow-upsHealth-related quality of life is measured by EuroQol visual analogue scale (EQ VAS). EQ VAS is a component of 5-level EQ-5D questionnaire. It measures patient's overall current health-related quality of life in a 20 cm visual analogue scale. The scale ranges from 100 ("the best health state you can imagine") to 0 ("the worst health you can imagine").
Presence of the ganglion6 months follow-upsThe presence of the ganglion will be assessed through clinical examination.
Duration of sick leave6 months follow-upsThe duration of sick leave is measured in days.
Adverse events3, 6, and 12 months follow-ups

Countries

Finland, Singapore

Contacts

CONTACTLasse Linnanmäki, MD, PhD
lasse.linnanmaki@fimnet.fi+3583311611

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026